MYX 3.29% $4.40 mayne pharma group limited

Ann: Mayne Pharma announces sale of US retail generics business, page-34

  1. 1,367 Posts.
    lightbulb Created with Sketch. 256
    Hope CEO remuneration contract has plenty of generous incentives , provided there's a decent improvement in share value cant see too many Mayne shareholders begrudging CEO being very well rewarded for his efforts , as for former CEO surely he must have been looking after the right people to have survived as long as he did his remuneration was absurd for doing what ? decimating LT retail shareholders capital .
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.40
Change
0.140(3.29%)
Mkt cap ! $374.3M
Open High Low Value Volume
$4.25 $4.43 $4.25 $618.9K 141.5K

Buyers (Bids)

No. Vol. Price($)
10 2957 $4.40
 

Sellers (Offers)

Price($) Vol. No.
$4.41 968 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.